SEC Tracker
Get the app

Intuitive Surgical ISRG

Intuitive Surgical reports $3.05B revenue

Form
10-Q
Filed
Importance
Major
  1. Revenue: $3.05 billion for the three months ended Sep 30, 2026
  2. Net income: $522.8 million for the three months ended Sep 30, 2026
  3. Diluted EPS: $1.49 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $2.98 billion at Sep 30, 2026

Written from the 10-Q on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Intuitive Surgical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

5 new legal mentions

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Revenue$3.05B$2.89B+5.4%
Operating income and margin$592.6M · 19.4%$971.9M · 33.6%−39%, margin −14.2 pts
Net income$522.8M$818.1M−36%
Operating cash flow$1.22B$1.06B+15%
Cash$2.98B$2.76B+7.9%
New legal mentions (5)
  • On August 13, 2026, the Ninth Circuit Court of Appeals issued an order reversing the district court s judgment and remanding the case for further proceedings.
  • In October 2026, following a mediation, the Company and plaintiffs reached a written agreement, without any admission of liability or wrongdoing by the Company, to settle the case for a one-time payment of $ 450 million and mutually agreed injunctive relief. +2 more paragraphs
  • This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act ). +7 more paragraphs
  • Following the Supreme Court s ruling, the U.S. imposed a temporary 10% import surcharge under Section 122 of the Trade Act of 1974. +1 more paragraph
  • Operating income included a charge of $450 million in connection with the settlement of antitrust class action litigation. +2 more paragraphs

Similar companies

Companies of similar size in SIC 3842 and related industry codes: the same peer list as the financial tables.

  1. Boston Scientific BSX public float $158.7B, Jun 30, 2025
  2. Stryker SYK public float $144.3B, Jun 30, 2025
  3. Medtronic MDT public float $120.1B, Oct 24, 2025
  4. 3M MMM public float $81.1B, Jun 30, 2025
  5. Becton Dickinson BDX public float $65.5B, Mar 31, 2025, over 18 months old